Literature DB >> 1975478

Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.

C F Xu1, M N Nanjee, J Savill, P J Talmud, F Angelico, M Del Ben, R Antonini, B Mazzarella, N Miller, S E Humphries.   

Abstract

We have used RFLPs of the apolipoprotein (apo) B gene and apo AI-CIII-AIV gene cluster to estimate the genetic contribution of variation at these loci to the variability of plasmid lipid, lipoprotein, and apolipoprotein levels in 209 children from Sezze in central Italy. The sample was randomly divided into group I (107 children) and group II (102 children). Four site polymorphisms (PvuII, XbaI, MspI, and EcoRI) of the apo B gene and five site polymorphisms (XmnI, PstI, SstI, PvuII-CIII, and PvuII-AIV) of the apo AI-CIII-AIV gene cluster were examined in group I children. After adjustment for gender, age, and body-mass index, polymorphisms at both gene loci (PvuII-B, PvuII-CIII, and PvuII-AIV) were associated with significant effects on the levels of plasma apo AI, apo B, or high-density lipoprotein-cholesterol. RFLPs that showed significant effects in group I were genotyped in group II. All three polymorphisms were associated with similar effects on apolipoprotein levels, though for all RFLPs the magnitude of the effects was smaller in the group II children and only statistically significant for the effect of the PvuII-B genotype on apo AI levels. In the total sample of 209 children 7.4% of the sample variance in apo AI levels was explained by variation associated with the apo B PvuII-B RFLP. In addition, the PvuII-B RFLP was associated with significant effects on plasma apo B levels and explained 5.7% of the sample variance. The PvuII-CIII and PvuII-AIV polymorphisms were both associated with differences in apo AI levels, explaining 3.7%-5.7% of the sample variance. Taken together, the three PvuII polymorphisms explained 17.7% of the phenotypic variance in apo AI levels. There was significant evidence for an effect of nonlinearity of the PvuII-CIII genotypes on apo AI levels, with the individuals heterozygous for the polymorphism having the highest apo AI levels. No evidence of interaction between genotype and gender, age, and body-mass index was shown by covariance analysis. The molecular explanation of this effect is unclear. Our data show that variation at both the apo AI-CIII-AIV and apo B loci are associated with lipoprotein and apolipoprotein levels in this sample of Italian children.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975478      PMCID: PMC1683867     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  57 in total

1.  Coronary heart disease risk factors in school children: the Muscatine study.

Authors:  R M Lauer; W E Connor; P E Leaverton; M A Reiter; W R Clarke
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

2.  DNA polymorphisms around the apo AI gene in normal and hyperlipidaemic individuals selected for a twin study.

Authors:  A M Kessling; K Berg; E Mockleby; S E Humphries
Journal:  Clin Genet       Date:  1986-06       Impact factor: 4.438

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Metabolic determinants of plasma high-density lipoprotein concentration in humans.

Authors:  N E Miller
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

5.  RFLPs for the human apolipoprotein B gene: HincII and PvuII.

Authors:  C Darnfors; J Nilsson; A A Protter; P Carlsson; P J Talmud; S E Humphries; J Whalström; O Wiklund; G Bjursell
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

6.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

7.  The isolation of genomic recombinants for the human apolipoprotein B gene and the mapping of three common DNA polymorphisms of the gene--a useful marker for human chromosome 2.

Authors:  N Barni; P J Talmud; P Carlsson; M Azoulay; C Darnfors; D Harding; D Weil; K H Grzeschik; G Bjursell; C Junien
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

8.  Major locus inheritance of apolipoprotein B in Utah pedigrees.

Authors:  S J Hasstedt; L Wu; R R Williams
Journal:  Genet Epidemiol       Date:  1987       Impact factor: 2.135

9.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

Authors:  J L Goldstein; H G Schrott; W R Hazzard; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

10.  Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences.

Authors:  M A Austin; M C King; R D Bawol; S B Hulley; G D Friedman
Journal:  Am J Epidemiol       Date:  1987-02       Impact factor: 4.897

View more
  4 in total

1.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.

Authors:  Robert Block; James Corsetti; Ilan Goldenberg; Gabriel Vorobiof; Scott McNitt; Daniel Ryan; Wojciech Zareba; Arthur J Moss
Journal:  Heart Int       Date:  2009-06-30

3.  Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones.

Authors:  A Kessling; S Ouellette; O Bouffard; A Chamberland; C Bétard; E Selinger; M Xhignesse; S Lussier-Cacan; J Davignon
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

4.  Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

Authors:  H Paul-Hayase; M Rosseneu; D Robinson; J P Van Bervliet; J P Deslypere; S E Humphries
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.